Delayed urticaria during treatment with anti‐ <scp>CGRP</scp> monoclonal antibodies in migraine
Anti-CGRP mAb-associated urticaria in this case series was delayed and likely non-immunoglobulin E (non-IgE)-mediated. Our experience supports that in selected patients with delayed urticaria, individualized management, including H1 antihistamine premedication, may allow continuation of effective migraine prophylaxis. Larger cohorts are needed to identify risk factors and to inform general management recommendations.
Authors
- Lukas Heydrich
- Athina Papadopoulou (ORCID: https://orcid.org/0000-0002-0367-1008)
- Severin B. Vogt (ORCID: https://orcid.org/0009-0007-3650-3549)
- Federico Burguet Villena (ORCID: https://orcid.org/0009-0009-9697-8364)
- Karin Hartmann
- Christoph T. Berger
Institutions
- University of Basel (CH)
- Kunstmuseum Basel (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Department of Biomedicine Basel (CH)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1111/head.70082
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00